Works by Wu, Shengjie

Results: 99
    1
    2

    MRI identifies disrupted cerebral development in medulloblastoma patients.

    Published in:
    Brain Communications, 2025, v. 7, n. 2, p. 1, doi. 10.1093/braincomms/fcaf090
    By:
    • Bag, Asim K;
    • Holtrop, Joseph;
    • Glass, John O;
    • McAfee, Samuel S;
    • Wu, Shengjie;
    • Li, Yimei;
    • Scoggins, Matthew;
    • Zhang, Silu;
    • Robinson, Giles W;
    • Gajjar, Amar;
    • Brinkman, Tara M;
    • Conklin, Heather M;
    • Reddick, Wilburn E
    Publication type:
    Article
    3

    A phase I trial and PK study of cediranib (AZD2171), an orally bioavailable pan-VEGFR inhibitor, in children with recurrent or refractory primary CNS tumors.

    Published in:
    Child's Nervous System, 2015, v. 31, n. 9, p. 1433, doi. 10.1007/s00381-015-2812-5
    By:
    • Kieran, Mark;
    • Chi, Susan;
    • Goldman, Stewart;
    • Onar-Thomas, Arzu;
    • Poussaint, Tina;
    • Vajapeyam, Sridhar;
    • Fahey, Frederic;
    • Wu, Shengjie;
    • Turner, David;
    • Stewart, Clinton;
    • Moses, Marsha;
    • Packer, Roger;
    • Jakacki, Regina;
    • Banerjee, Anu;
    • Boyett, James;
    • Fouladi, Maryam;
    • Kun, Larry
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Phase I and pharmacokinetic trial of PTC299 in pediatric patients with refractory or recurrent central nervous system tumors: a PBTC study.

    Published in:
    Journal of Neuro-Oncology, 2015, v. 121, n. 1, p. 217, doi. 10.1007/s11060-014-1665-1
    By:
    • Packer, Roger;
    • Rood, Brian;
    • Turner, David;
    • Stewart, Clinton;
    • Fisher, Michael;
    • Smith, Christopher;
    • Young-Pouissant, Tina;
    • Goldman, Stewart;
    • Lulla, Rishi;
    • Banerjee, Anu;
    • Pollack, Ian;
    • Kun, Larry;
    • Onar-Thomas, Arzu;
    • Wu, Shengjie;
    • Boyett, James;
    • Fouladi, Maryam
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Working Memory Performance among Childhood Brain Tumor Survivors.

    Published in:
    Journal of the International Neuropsychological Society, 2012, v. 18, n. 6, p. 996, doi. 10.1017/S1355617712000793
    By:
    • Conklin, Heather M.;
    • Ashford, Jason M.;
    • Howarth, Robyn A.;
    • Merchant, Thomas E.;
    • Ogg, Robert J.;
    • Santana, Victor M.;
    • Reddick, Wilburn E.;
    • Shengjie Wu;
    • Xiaoping Xiong
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    Corrigendum to: LTBK-01. Updates On The Phase Ii And Re-treatment Study Of AZD6244 (Selumetinib) For Children With Recurrent Or Refractory Pediatric Low Grade Glioma: A Pediatric Brain Tumor Consortium (PBTC) Study.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 8, p. 1404, doi. 10.1093/neuonc/noac029
    By:
    • Fangusaro, Jason R;
    • Onar-Thomas, Arzu;
    • Poussaint, Tina Young;
    • Wu, Shengjie;
    • Ligon, Azra H;
    • Lindeman, Neal Ian;
    • Banerjee, Anuradha;
    • Packer, Roger;
    • Kilburn, Lindsay B;
    • Pollack, Ian F;
    • Qaddoumi, Ibrahim A;
    • Fisher, Paul Graham;
    • Dhall, Girish;
    • Baxter, Patricia Ann;
    • Kreissman, Susan G;
    • Doyle, L Austin;
    • Smith, Malcolm A;
    • Fouladi, Maryam;
    • Dunkel, Ira J
    Publication type:
    Article
    37

    Phase II trial of response-based radiation therapy for patients with localized germinoma: a Children's Oncology Group study.

    Published in:
    Neuro-Oncology, 2022, v. 24, n. 6, p. 974, doi. 10.1093/neuonc/noab270
    By:
    • Bartels, Ute;
    • Onar-Thomas, Arzu;
    • Patel, Sunita K;
    • Shaw, Dennis;
    • Fangusaro, Jason;
    • Dhall, Girish;
    • Souweidane, Mark;
    • Bhatia, Aashim;
    • Embry, Leanne;
    • Trask, Christine L;
    • Murphy, Erin S;
    • MacDonald, Shannon;
    • Wu, Shengjie;
    • Boyett, James M;
    • Leary, Sarah;
    • Fouladi, Maryam;
    • Gajjar, Amar;
    • Khatua, Soumen
    Publication type:
    Article
    38

    A phase II trial of selumetinib in children with recurrent optic pathway and hypothalamic low-grade glioma without NF1: a Pediatric Brain Tumor Consortium study.

    Published in:
    Neuro-Oncology, 2021, v. 23, n. 10, p. 1777, doi. 10.1093/neuonc/noab047
    By:
    • Fangusaro, Jason;
    • Onar-Thomas, Arzu;
    • Poussaint, Tina Young;
    • Wu, Shengjie;
    • Ligon, Azra H;
    • Lindeman, Neal;
    • Campagne, Olivia;
    • Banerjee, Anu;
    • Gururangan, Sridharan;
    • Kilburn, Lindsay B;
    • Goldman, Stewart;
    • Qaddoumi, Ibrahim;
    • Baxter, Patricia;
    • Vezina, Gilbert;
    • Bregman, Corey;
    • Patay, Zoltan;
    • Jones, Jeremy Y;
    • Stewart, Clinton F;
    • Fisher, Michael J;
    • Doyle, Laurence Austin
    Publication type:
    Article
    39
    40

    LGG-02. A PHASE II PROSPECTIVE TRIAL OF SELUMETINIB IN CHILDREN WITH RECURRENT/PROGRESSIVE PEDIATRIC LOW-GRADE GLIOMA (PLGG) WITH A FOCUS UPON OPTIC PATHWAY/HYPOTHALAMIC TUMORS AND VISUAL ACUITY OUTCOMES: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY, PBTC-029B

    Published in:
    Neuro-Oncology, 2019, v. 21, p. ii98, doi. 10.1093/neuonc/noz036.145
    By:
    • Fangusaro, Jason;
    • Onar-Thomas, Arzu;
    • Poussaint, Tina Young;
    • Wu, Shengjie;
    • Ligon, Azra H;
    • Lindeman, Neal;
    • Banerjee, Anu;
    • Packer, Roger J;
    • Kilburn, Lindsay B;
    • Goldman, Stewart;
    • Pollack, Ian F;
    • Jakacki, Regina I;
    • Qaddoumi, Ibrahim;
    • Fisher, Paul G;
    • Dhall, Girish;
    • Baxter, Patricia;
    • Kreissman, Susa G;
    • Stewart, Clinton F;
    • Jones, David T W;
    • Pfister, Stefan M
    Publication type:
    Article
    41

    A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 8, p. 1135, doi. 10.1093/neuonc/now282
    By:
    • Banerjee, Anuradha;
    • Jakacki, Regina I.;
    • Onar-Thomas, Arzu;
    • Shengjie Wu;
    • Nicolaides, Theodore;
    • Poussaint, Tina Young;
    • Fangusaro, Jason;
    • Phillips, Joanna;
    • Perry, Arie;
    • Turner, David;
    • Prados, Michael;
    • Packer, Roger J.;
    • Qaddoumi, Ibrahim;
    • Gururangan, Sridharan;
    • Pollack, Ian F.;
    • Goldman, Stewart;
    • Doyle, Lawrence A.;
    • Stewart, Clinton F.;
    • Boyett, James M.;
    • Kun, Larry E.
    Publication type:
    Article
    42

    Phase 1 trial of p28 (NSC745104), a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in pediatric patients with recurrent or progressive central nervous system tumors: A Pediatric Brain Tumor Consortium Study.

    Published in:
    Neuro-Oncology, 2016, v. 18, n. 9, p. 1319, doi. 10.1093/neuonc/now047
    By:
    • Lulla, Rishi R.;
    • Goldman, Stewart;
    • Tohru Yamada;
    • Beattie, Craig W.;
    • Bressler, Linda;
    • Pacini, Michael;
    • Pollack, Ian F.;
    • Fisher, Paul Graham;
    • Packer, Roger J.;
    • Dunkel, Ira J.;
    • Dhall, Girish;
    • Shengjie Wu;
    • Onar, Arzu;
    • Boyett, James M.;
    • Fouladi, Maryam
    Publication type:
    Article
    43
    44

    Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study.

    Published in:
    Neuro-Oncology, 2014, v. 16, n. 2, p. 310, doi. 10.1093/neuonc/not154
    By:
    • Gururangan, Sridharan;
    • Fangusaro, Jason;
    • Poussaint, Tina Young;
    • McLendon, Roger E.;
    • Onar-Thomas, Arzu;
    • Wu, Shengjie;
    • Packer, Roger J.;
    • Banerjee, Anu;
    • Gilbertson, Richard J.;
    • Fahey, Frederic;
    • Vajapeyam, Sridhar;
    • Jakacki, Regina;
    • Gajjar, Amar;
    • Goldman, Stewart;
    • Pollack, Ian F.;
    • Friedman, Henry S.;
    • Boyett, James M.;
    • Fouladi, Maryam;
    • Kun, Larry E.
    Publication type:
    Article
    45
    46

    Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022).

    Published in:
    2013
    By:
    • Fangusaro, Jason;
    • Gururangan, Sridharan;
    • Poussaint, Tina Young;
    • McLendon, Roger E;
    • Onar-Thomas, Arzu;
    • Warren, Katherine E;
    • Wu, Shengjie;
    • Packer, Roger J;
    • Banerjee, Anu;
    • Gilbertson, Richard J;
    • Jakacki, Regina;
    • Gajjar, Amar;
    • Goldman, Stewart;
    • Pollack, Ian F;
    • Friedman, Henry S;
    • Boyett, James M;
    • Kun, Larry E;
    • Fouladi, Maryam
    Publication type:
    journal article
    47

    Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11).

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 23, p. 4180, doi. 10.1002/cncr.28343
    By:
    • Fangusaro, Jason;
    • Gururangan, Sridharan;
    • Poussaint, Tina Young;
    • McLendon, Roger E.;
    • Onar‐Thomas, Arzu;
    • Warren, Katherine E.;
    • Wu, Shengjie;
    • Packer, Roger J.;
    • Banerjee, Anu;
    • Gilbertson, Richard J.;
    • Jakacki, Regina;
    • Gajjar, Amar;
    • Goldman, Stewart;
    • Pollack, Ian F.;
    • Friedman, Henry S.;
    • Boyett, James M.;
    • Kun, Larry E.;
    • Fouladi, Maryam
    Publication type:
    Article
    48
    49
    50

    Evaluating pediatric spinal low-grade gliomas: a 30-year retrospective analysis.

    Published in:
    Journal of Neuro-Oncology, 2019, v. 145, n. 3, p. 519, doi. 10.1007/s11060-019-03319-4
    By:
    • Carey, Steven S.;
    • Sadighi, Zsila;
    • Wu, Shengjie;
    • Chiang, Jason;
    • Robinson, Giles W.;
    • Ghazwani, Yahya;
    • Liu, Anthony P. Y.;
    • Acharya, Sahaja;
    • Merchant, Thomas E.;
    • Boop, Frederick A.;
    • Gajjar, Amar;
    • Qaddoumi, Ibrahim
    Publication type:
    Article